Is Exelixis, Inc. Stock Doomed?
Biotech stocks are infamous for their volatile ways — shooting higher one minute, only to crater the next. After a biotech crashes, investors should always assess their options going forward. Sometimes a marked sell-off represents a compelling buying opportunity that can pay off handsomely over the long run. On the other hand, a mass shareholder exodus can trigger a series of events […]